Clinical Trial Update: A Study of Dual-SIgnaling Protein 107 (DSP107) for Patients With Hematological Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 study of Dual-Signaling Protein 107 (DSP107) in hematologic malignancies has been terminated, including studies in Acute Myeloid Leukemia, Myelodyspla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Myelomonocytic Leukemia

Drugs mentioned

• DSP107

Snippet

Sponsor: Kahr Medical | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 1 | Status: TERMINATED